stain cells before SEM study, thus making identification easier.
Cell samples were prepared (1) by scraping from the cervix, staining and processing for SEM study and (2) by removing cells from colposcopically directed areas on the cervix with a membrane filter. A total of 138 patients were studied and characteristic differences were noted between the surface ultrastructure of benign and malignant cells. Dyskariotic cells showed a mixture of surface types between normal and frankly abnormal. Differences were observed in the SEM between cells that appeared identical by light microscopy. In particular, a tendency to surface abnormality existed on cells that were normal by light microscopy when the cells were adjacent to abnormal cells. A method of assay of CEA not requiring prior extraction has been described. Various essential criteria for a valid radioimmunoassay have been fulfilled; the use of a preparation of labelled CEA reasonably freed of contaminants and of molecules damaged by the labelling reaction, acquisition of specific antibodies, use of an efficient system of separation of free labelled CEA from that bound to antibody (the double antibody technique) and application of the assay method to biological fluids, in particular, serum. The sensitivity of this method allows the detection of 0 5-1 ng/ml of serum; the precision and the reproducibility of the results are very satisfactory.
MEASUREMENT
CEA could be detected in the serum of only 4.2% of 1017 normal subjects. In another group of 7 patients without evidence of urinary infection CEA was determined before and after therapy. In 5
